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Abstract
Background & Aims—Reports of complications among adult right hepatic lobe donors have
been limited to single centers. The rate and severity of complications in living donors were
investigated in the 9-center Adult-to-Adult Living Donor Liver Transplantation Cohort Study
(A2ALL).
Methods—A retrospective observational study design was used. Participants included all
potential living donors evaluated between 1998 and 2003. Complication severity was graded using
the Clavien scoring system.
Results—Of 405 donors accepted for donation, 393 underwent donation, and 12 procedures were
aborted. There were 245 donors (62%) who did not experience complications; 82 (21%) had 1
complication, and 66 (17%) had 2 or more. Complications were scored as grade 1 (minor; n = 106,
27%), grade 2 (potentially life threatening; n = 103, 26%), grade 3 (life threatening; n = 8, 2%),
and grade 4 (leading to death; n = 3, 0.8%). Common complications included biliary leaks beyond
postoperative day 7 (n = 36, 9%), bacterial infections (n = 49, 12%), incisional hernia (n = 22,
6%), pleural effusion requiring intervention (n = 21, 5%), neuropraxia (n = 16, 4%), reexploration
(n = 12, 3%), wound infections (n = 12, 3%), and intraabdominal abscess (n = 9, 2%). Two donors
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developed portal vein thrombosis, and 1 had inferior vena caval thrombosis. Fifty-one (13%)
donors required hospital readmission, and 14 (4%) required 2 to 5 readmissions.
Conclusions—Adult living liver donation was associated with significant donor complications.
Although most complications were of low-grade severity, a significant proportion were severe or
life threatening. Quantification of complication risk may improve the informed consent process,
perioperative planning, and donor care.
The rising demand for orthotopic liver transplantation in the United States has continued to
outpace the availability of deceased donor organs.1 Efforts to increase deceased liver
donation have seen only modest successes. Rising rates of death on the waiting list led to the
use of more innovative and risky approaches to transplantation, including reduced size and
split liver organs and, more recently, living donors.2–7
Although potentially lifesaving for the recipient, living donor liver transplantation (LDLT)
is a unique surgical procedure that subjects a healthy donor to a major surgical procedure
without direct therapeutic benefits.8 This procedure is distinguished by the “double
equipoise” that is imposed on both the donor and the recipient.9 LDLT was initially used in
pediatric transplantation, employing left lobe or left lateral segment donation usually from
an adult parent to his or her infant or small child.5 The ethics of exposing a healthy person to
a risky surgical procedure in this situation was tempered by the relatively low rate of serious
complications of left lobe or lateral segment resection and the emotional and personal
benefits to a parent who makes a sacrifice for the health of his or her child.
Adult-to-adult LDLT was introduced almost a decade after LDLT for children and
immediately increased concerns over donor safety. Adult-to-adult LDLT requires right or
left lobe resection (~30%–60% of the total liver mass) and usually depends on donation
from a spouse or adult relative. The initial reports of high recipient successes and low donor
morbidity rates10,11 led to rapid expansion of adult-to-adult LDLT, and, by 2001, this
procedure accounted for more that 400 transplantations (~10% of all adult liver
transplantations done in the United States that year). However, following a well-publicized
donor death in 2002,12 rates of adult-to-adult LDLT declined precipitously and have
remained in the range of 250–300 per year subsequently. A major reassessment of the risks
of right lobe liver donation has led to a more cautious approach to the use of this procedure.
Unfortunately, despite almost 10 years of experience with adult-to-adult LDLT in the United
States, the risks of right lobe liver donation have not been well characterized. Most reports
of complications of adult-to-adult LDLT are based on single transplant program experience.
The rates of complications in these single center publications ranged from as low as 9% to
as high as 67%.11,13–21 In a national survey from North America, the overall donor
complication rate was reported to be only 10%.22 The lack of uniformity in defining
complications and underreporting of technical complications, blood and blood product
transfusions, and aborted donations all contribute to the lack of firm information about the
risks of right lobe liver donation.
The Adult-to-Adult Living Donor Liver Transplantation (A2ALL) Cohort Study was
initiated in 2002 as a cooperative research agreement funded by National Institutes of Health
with 9 liver transplant centers and a data coordinating center. The A2ALL Study was
developed with the specific aim of providing accurate information on the risks and benefits
of adult-to-adult LDLT for both donors and recipients. Retrospective and prospective studies
were initiated. For assessing complications, the uniform reporting of adverse outcomes of
surgery proposed by Clavien et al23,24 was adopted. This classification and severity scoring
system (Table 1) defined complications as unexpected events that were not inherent to the
procedure. Originally developed for general surgical procedures, this system has been
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widely adopted in liver transplantation25 for standardization of reporting of complication
rates for both donors and recipients. The current report analyzed complication rates among
adult LDLT donors from the 9 transplant centers based on the A2ALL retrospective cohort.
Patients and Methods
Study Population
A full description of the donor evaluation process has recently been reported.26 Data were
collected on all potential living liver donors who were evaluated between January 1, 1998,
and February 28, 2003, at 9 US centers using a uniform comprehensive medical record
review process. Of 1011 potential donors evaluated, 405 were accepted and went to the
operating room with the intention to donate. There were 392 completed adult LDLT
donations. Twelve procedures were aborted after the donor entered the operating room but
prior to liver resection, and the resected right hepatic lobe of 1 additional donor was not
transplanted into the intended recipient because of intraoperative death of the recipient. The
median follow-up was 6 months (range, 5 days to 5.6 years).
Definitions and Data Collection
A structured data collection form based on the Clavien grading system was applied to the
donation and postdonation experience of each donor. An electronic data entry system was
used by the study coordinators at each site. Clavien severity scoring of complications was
performed at the data coordinating center based on information provided by the sites.
Complications among donors whose procedures were completed were evaluated and graded
where applicable. The intraoperative experiences and the complications of the donors with
aborted procedures were examined and reported separately. Intraoperative hypotension,
defined as systolic blood pressure ≤100 mm Hg, was not considered a complication because
several of the participating centers purposefully allowed low blood pressures during the time
of liver resection. On medical record/chart review, we were not able to determine whether
the blood pressure was purposefully lowered or whether it was an inadvertent occurrence.
However, hypotension was tested as a predictive covariate in statistical models associated
with donor complications.
Residual left lobe weight according to preoperative imaging was used as an estimate of
remnant liver volume where available. As an alternative, standard liver volume (SLV)*0.4
was used, based on excellent correlation between graft size and the formula estimate among
cases in which both have been measured.27 For each center’s LDLT procedures, a sequential
case number was assigned to each adult-to-adult LDLT performed. Each adult-to-adult
LDLT was then categorized as having occurred when the center was less experienced or
more experienced based on case numbers ≤20 or >20, respectively.28
Statistical Analysis
Descriptive statistics are reported as ranges, means, standard deviations (SD), and
proportions as appropriate. The Kaplan–Meier method was used to estimate the probability
of rehospitalization after donation. Logistic regression analysis was used to assess the
association of predictive variables with overall donor complications and with biliary
complications. Results are presented as adjusted odds ratios. The covariates that were tested
in both models included donor sex, age, race, ethnicity, body mass index (BMI), alkaline
phosphatase, total bilirubin, donor relationship to recipient, evaluation year, transplant
center, LDLT case number, center LDLT experience (more experience or less experience),
number of bile ducts from the right lobe, intraoperative hypotension (yes/no), intraoperative
blood transfusions, remnant liver size, and total duration of the donor operative procedure.
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All analyses were carried out using SAS 9.1 statistical software (SAS Institute Inc, Cary,
NC).
Human Subjects Protection
The study was approved by the institutional review boards and privacy boards of the




The characteristics of the 405 adults accepted for liver donation are shown in Table 2. All
donors were adults below the age of 60 years. They were mainly non-Hispanic whites, and
slightly over half were male. Sixty percent of donors were overweight or obese, the average
BMI being 26 (kg/m2). Two thirds of donors were biologically related to the recipient; adult
sons and daughters were the most frequent relationships.
Aborted Donations and Orphan Grafts
A total of 13 of the 405 donor operations were aborted after arrival in the operating room.
One potential donor declined donation in the operating room prior to induction of general
anesthesia. In 1 case, the resection was completed, but the graft was not transplanted
because of the intraoperative death of the recipient. Another donor underwent surgery with
division of the parenchyma, but further division of bile ducts and vasculature was aborted
because the intended recipient became unstable.
In the remaining 10 donor procedures, an incision was made, but the donor liver was not
divided: in 4 instances, the liver was judged to be of poor quality because of steatosis,
granulomas, or unspecified inadequacies; in 3 instances there were dense adhesions or small,
aberrant bile ducts; and, in 3 instances, the discovery of intraoperative findings in the
recipient contraindicated transplantation. There was no significant difference in the BMI
between aborted and actual donors (mean, 28.5; range, 21.3–43.4 vs mean, 26.2; range,
17.4–41, respectively; P = .09).
Morbidity among the 12 aborted donations included 2 grade 1 complications and 1
intraoperative systolic blood pressure of <100 mm Hg. In addition, the donor who
underwent division of the parenchyma suffered a grade 2 complication because of bile leak,
bacterial infection, and localized intraabdominal abscess. All donor complications after
aborted donations were known to have resolved without permanent sequelae at the last
follow-up.
Donor Surgery
Intraoperative features are shown in Table 3 for the 393 donors whose resection procedures
were completed. The average remnant liver weight was 582 g (range, 180–1152 g). The
operative time was available on 84% of donors and averaged 7.6 hours (range, 4–15.5
hours). Approximately one third of donors required blood transfusion, and, among these,
most received 1 or 2 units of packed red blood cells. The high occurrence of systolic
hypotension (22%) reflected in part a decision to permit low intraoperative systemic blood
pressure at some of the A2ALL transplant centers.
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The average length of hospital stay for donation surgery was 7 days (range, 2–28 days), and
half of the donors were hospitalized for at least 7 days (Table 4). After discharge, 51 donors
(13%) were rehospitalized at least once and 14 (4%) on more than 1 occasion. Among 51
first rehospitalizations, two-thirds occurred within 90 days of the donation (Figure 1), and
only 2 occurred more than 2 years (2.9 and 4.6 years) after donation. According to Kaplan–
Meier analysis, the probabilities of rehospitalization were 10% and 23% at 3 months and 2
years postdonation, respectively.
Overall Donor Morbidity and Severity
The majority of donors (n = 245; 62%) did not suffer any complications, defined by the
Clavien classification as any alteration from the ideal postoperative course with complete
recovery. However, 148 donors (38%) had a total of 220 complications (Table 5). Eighty-
two donors (21%) had 1 complication, 40 (10.2%) had 2 complications, 16 (4.1%) had 3
complications, and 10 (2.6%) had 4 to 7 complications.
Approximately half of the complications were classified as grade 1 (minor, n = 106; 48%)
and half as grade 2 (no lasting disability, n = 103; 47%). There were 8 grade 3 (lasting
disability) and 3 grade 4 (death) complications. One patient died from infection and
multiorgan system failure during the initial donation hospitalization, and the other 2 died
more than a year after donation from drug overdose and suicide, respectively. A fourth
death, which did not relate to a graded complication, was the result of a train accident. These
deaths have been described in detail elsewhere.29
Forty-six percent of all complications and 45% of grade 3 or 4 complications occurred
during the initial hospitalization. For the 5 donors with grade 3 or 4 complications during the
initial hospitalization, the mean length of that hospitalization was 12.8 days (range, 7–22
days).
Intraoperative Complications
Intraoperative complications occurred in 10 donors (2.5%). Reported intraoperative injuries
included lacerations of the right hepatic vein and left portal vein and tears to the liver
capsule. Other intraoperative complications, in 5 separate donors, included intraabdominal
bleeding, portal vein clamp slippage with 500-mL blood loss, pneumothorax, hypotension,
and a reaction to intraoperative blood transfusion. Another donor had transient immediate
postoperative hypoxemia thought to be due to narcotic overdosage.
Postoperative Complications
The most common postoperative complications were infections (12.5%), biliary leak
(persistent leak beyond postoperative day 7) (9.2%), and incisional hernia (5.6%). These
were also the most common grade 2 or greater complications. Liver decompensation or
hepatic artery thrombosis did not occur. However, portal vein thrombosis occurred in 2
donors: one required operative thrombectomy with subsequent intensive care unit stay and
14 days of hospitalization, and the other was managed by radiologic intervention and
medical treatment. Both events resolved within 3 months. One donor had inferior vena cava
thrombosis that resolved with radiologic and medical management. No instances of
myocardial infarction, heart failure, or deep venous thrombosis were observed, but there was
a notable frequency of pleural effusions (5.3%) that required thoracentesis or thoracostomy.
Two surgical complications required treatment at the time of reexploration. A redundant
remnant of the cystic duct was excised after causing a post-cholecystectomy syndrome. In
the other case, a liver remnant that had rotated into the right upper quadrant was remobilized
and repositioned. Neuropraxia occurred in 16 donors, 2 of whom had lasting disability. The
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most common psychologic complication was depression, which was usually identified well
after the transplant hospitalization.
Factors Associated With Donor Complications
Univariable and multivariable analyses were employed using logistic regression to assess
associations between donor and operative characteristics and the likelihood of
complications. Among all the tested donor characteristics, only intraoperative blood
transfusion was associated with a significantly higher risk of at least 1 complication among
donors in both univariable and multivariable analyses using logistic regression (Table 6).
Compared with donors who required no blood transfusions, those who received up to 1 unit
had 2.7 times the odds of complications, and more than 1 unit of transfusion was associated
with an odds ratio of 4.5.
Significant predictors of biliary complications included higher predonation alkaline
phosphatase levels and intraoperative blood transfusions in both univariable analyses and
multivariable logistic regression. Donors in the highest quartile of alkaline phosphatase
activity (86–197 IU/L) had more than 3 times the odds of developing biliary complications
as those with lower activity (Table 6). Three of 8 (37.5%) donors with predonation alkaline
phosphatase greater than 150 IU/L (the highest laboratory upper limit of normal among the 9
centers) developed biliary complications. Compared with donors who did not require blood
transfusion, those who received blood transfusion had 3 times the odds of developing biliary
complications. As shown in Table 7, the predicted probability of any complication increased
from 0.29 for no transfused blood to 0.65 for greater than 1 unit of blood. Similarly, the
predicted probability of biliary complications increased with higher levels of alkaline
phosphatase and blood transfusion. Duration of surgery was associated with neither the
likelihood of any complications (P = .45) nor of biliary complications (P = .76).
We examined the rate of donor complications according to narrow categories of transplant
center adult-to-adult LDLT experience (first 5 LDLTs, second 5 LDLTs, and so on). There
was no obvious threshold or statistically significant trend in the occurrence of any
complication (P = .59), the total number of complications (P = .97), or the occurrence of
biliary complications (P = .39) based on center adult-to-adult LDLT experience. However,
the 3 grade 4 complications that led to death occurred during the early center experience (the
first 20 adult-to-adult LDLT), even though the drug overdose and suicide occurred more
than a year after the transplantation.
Discussion
It could be argued that adult-to-adult LDLT should not be considered an option for liver
transplantation unless the risk to donors can be well-defined. Therefore, one of the principal
aims of the A2ALL Study, and the main point of this report, was to identify the extent and
severity of complications in adult living liver donors in an unbiased and standardized
fashion. Incorporation of a widely used instrument for reporting complications greatly
facilitated this effort. Across the 9 A2ALL centers, the overall complication rate was 38%.
Donor complication rates derived from single centers and surveys across the United States
have generally been lower than this figure, but some have been higher. Similar variability
has been seen in reports of single center experiences outside the United States. A report
from Hong Kong of 100 donors indicated an overall major complication rate of 14% that
was reduced to 6% in their second 50 patients.30 Minor complications decreased from 26%
to 8%. In a recent study from Taiwan, only 10 of 205 (4.9%) donors suffered
complications.19 Complications in 9 of 43 right lobe donors were reported from Kyoto.31
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One possible explanation for the variation in complication rates could be transplant center
and operative experience. Because the current study found no relationship between center
experience and donor outcomes, this is unlikely to be the only explanation for rate variation.
Furthermore, the few donor deaths that have been reported worldwide have generally
occurred at experienced centers.32 An equally plausible explanation is that variation in
complication rates across studies may reflect the lack of consistent definitions of surgical
complications. Whereas some centers have included minor complications, others have only
reported severe or life-threatening events. In our study, we defined complications as
unexpected events that were not inherent to the procedure.22,23 Complications were further
graded by severity to allow accurate comparisons.23,24 Although there was a more recent
modification33 of this system, we utilized the earlier version based on ease of application, a
larger volume of reported experience, and its recent adoption by the international liver
community.34 Nearly half of the complications in the current study were grade 1. Although
the initial donor hospitalization was a relatively short 7 days, the cumulative readmission
rate was 23% at 2 years. The majority of rehospitalizations occurred in the first 90 days, but
8 donors were rehospitalized beyond the first year.
The retrospective cohort design of the current study is an admitted shortcoming because it
relied primarily on medical record abstraction for data collection. This may have resulted in
incomplete capture of some relevant variables. As an example, we did not collect data on
postoperative liver function tests because this information was not available at consistent
intervals across the centers. Sites did not all measure the weight of the resected donor lobe,
so, in some cases, calculated estimates were used. However, there were good correlations
between the estimates and actual weights in instances in which the latter were available.
Similarly, data on other issues such as pain and quality of life, although not available for the
retrospective study, are being evaluated in the prospective component of the A2ALL Study
that was initiated in 2004.
Previously dismissed as a rare event, donations were aborted in 3% of the A2ALL cohort
who went to the operating room. One of these patients underwent division of the liver
parenchyma and subsequently developed a grade 1 bile leak. In an additional case, the liver
became an “orphan” graft when the recipient died prior to engraftment. Such an event raises
the ethical dilemma of giving an orphan graft to an unrelated and unplanned for
recipient.35,36 Additionally, it is obvious that an aborted donation makes the donor
susceptible to morbidity.
Certain individual complications are worth highlighting. Biliary complications have been
one of the major concerns in adult LDLT donors and recipients. In this study, biliary
complications were the second most common category of donor morbidity, occurring in
nearly 10% of cases. The majority were grade 2 complications, which are considered, by
definition, to be potentially life threatening or to have markedly prolonged intensive care
unit stay or hospitalization. Another common complication was incisional hernia, affecting
more than 5% of donors. This rate is similar to that reported after other major abdominal
surgical procedures but is perhaps surprising among healthy individuals undergoing elective
surgery. Brachial plexus injury resulting in neuropraxia was also relatively common and
resulted in lasting neuromuscular disability for 2 donors. This injury usually results from
malpositioning on the operating table during a prolonged procedure. In fact, mean operative
time was 455 minutes for those without neuropraxia and 530 minutes for those with
neuropraxia (P = .056). This can result in major functional disability, as well as permanent
work disability for donors whose occupations depend on motor function of the arm.
An important contribution of the current study was the identification of preoperative and
intraoperative factors significantly associated with complications after living liver donation.
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Intraoperative blood transfusion was the only variable that was significantly associated with
the overall rate of complications (P < .001) and 1 of only 2 predictors of biliary
complications. Blood loss and ensuing transfusion may be surrogate markers for surgical
complexity and/or the quality of the donor liver. Interestingly, the duration of the surgical
procedure was not independently associated with a significantly higher likelihood of
complications. Thus, meticulous time-consuming dissection may be a prudent approach for
reducing donor complications. Our results are consistent with a reported study of 204 right
and left lobe donors in which operative blood loss and number of segments resected were
found to be significant independent predictors of complications.19 In addition to blood
transfusion, we found that higher preoperative donor alkaline phosphatase was strongly
associated with postdonation biliary complications (P < .01). This association is intriguing
and unexplained. From our retrospective observational cohort, it cannot be determined
whether the alkaline phosphatase was largely liver derived or whether there might be
unmeasured confounders that could have accounted for this observation. In fact, we are
unaware of experimental or other observational data that would inform this finding. Because
there is no other situation in medicine in which well-evaluated and presumably healthy
individuals undergo removal of more than half of their liver, it is difficult to determine the
implications of this finding. The correlation of alkaline phosphatase with liver biopsy and/or
computed tomographic cholangiography findings may be examined in the prospective study.
It is possible that modest alkaline phosphatase elevation suggests donor susceptibility to
intraoperative ischemia, and the need for blood transfusion suggests possible exposure to an
ischemic event, with the combination resulting in biliary complications. Our findings require
validation and perhaps greater scrutiny of donors with high normal or slightly elevated
alkaline phosphatase.
One important finding was the lack of an association between center LDLT experience and
donor complications. This observation is in contrast to the corresponding A2ALL analyses
of recipient outcomes and its predictors, in which a “learning curve” was identified and
recipient outcomes improved after center experience with more than 20 adult-to-adult LDLT
procedures.28 The lack of a significant association between center experience and donor
complications may indicate that surgical experience with hepatic resections outside the
transplantation setting provides adequate training for the adult donor operation in LDLT but
could also represent a type II error. Larger numbers of cases with more intensive follow-up
of donors in the A2ALL prospective cohort study may yet identify other important
predictors of complications that could be eliminated or ameliorated.
In summary, systematic data collection using a consistent and accepted classification system
in this large multicenter study has documented the frequency and severity of complications
among adult LDLT donors. This information should be used for the education and informed
consent process for potential donors. Its greatest value may be realized well before
transplantation, when a potential adult recipient is being considered for placement on the
deceased donor waiting list and for LDLT. From the standpoint of management, meticulous
surgical technique that prevents blood loss and the need for transfusion while avoiding
hepatic ischemia may reduce the incidence of complication in adult donors. The association
of postoperative biliary tract complications with alkaline phosphatase levels in the high
normal range was an unanticipated finding and deserves further study.
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Table 1
Clavien System for Classification of Negative Outcomes in General Surgery and Solid Organ Transplantation
Grade 1 Any alteration from the ideal postoperative course, with complete recovery or which can be easily controlled and which fulfills the
following general characteristics:
a. Not life threatening;
b. not requiring use of drugs other than immunosuppressants; analgesics; antipyretics; antiinflammatory agents;
antiemetics; drugs required for urinary retention or lower urinary tract infection, arterial hypertension, hyperlipidemia, or
transient hyperglycemia;
c. requiring only therapeutic procedures that can be performed at the bedside;
d. postoperative bleeding requiring ≤3 units of blood transfusion; and
e. never associated with a prolongation of intensive care unit stay or total hospital stay to more than twice the median stay
for the procedure in the population of the study.
Grade 2 Any complication that is potentially life threatening or results in intensive care unit stay >5 days, hospital stay >4 weeks for the
recipient, but which does not result in residual disability or persistent disease
Grade 3 Any complication with residual or lasting functional disability or development of malignant disease
Grade 4 Complications that lead to retransplantation (grade 4a) or death (grade 4b)
NOTE. Adapted from references Brown et al22 and Clavien et al.23,24
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Table 2
Characteristics of Accepted Adult Living Liver Donors
Characteristic N Range Mean (SD) or percent
Age, y 404 18–59 37 (9.6)
Sex
 Female 182 45
 Male 223 55
Ethnicity
 Hispanic/Latino 68 17
 Non-Hispanic/non-Latino 335 83
 Missing 2 1
Race
 White 366 90
 African American 15 4
 Asian 13 3
 Other 9 2
 Missing 2 1
Height (cm) 397 150–203 173 (10.0)
Weight (kg) 402 43–141 78 (15.0)
Body mass index (kg/m2) 397 17–43 26 (3.9)
 <20 19 5
 ≥20 to <25 136 34
 ≥25 to <30 182 45
 ≥30 60 15
 Missing 8 2
Relatedness to recipient
 Biologically related
  Parent 9 2
  Child 139 34
  Sibling 92 23
  Other biological 35 9
 Not biologically related
  Spouse 51 13
  Other nonbiological 78 19
 Unknown/missing 1 <1
Alkaline phosphatase (IU/L) 403 21–197 74 (26)
 ≤58 102 25
 >58 to ≤69 103 26
 >69 to ≤86 98 24
 >86 to ≤197 100 25
Bilirubin (IU/L) 403 0.1–2.8 0.72 (0.4)
 ≤0.5 134 33
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Characteristic N Range Mean (SD) or percent
 >0.5 to ≤0.7 123 31
 >0.7 to ≤0.9 70 17
 >0.9 to ≤2.8 76 19
NOTE. N = 405. Accepted donors were the donors who were accepted for liver donation and went to the operating room with the intention to
donate.
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Table 3
Intraoperative and Postoperative Characteristics of Donors
Characteristic N Range Mean (SD) or percent
Remnant liver weight (g)a 388 180–1152 582 (156)
 ≥180 to ≤480 98 25
 >480 to ≤582 99 25
 >582 to ≤681 95 24
 >681 to ≤1152 96 24
Units of transfused blood 387 0–4 0.4 (0.8)
 0 267 68
 >0 to ≤1 84 21
 >1 to ≤2 26 7
 >2 to ≤3 6 2
 >3 to ≤4 4 1
Hypotension (<100 mm Hg systolic)
 Yes 88 22
 No 288 73
 Missing 17 4
Operative time (min) 329 236–930 458 (133)
 ≥236 to ≤358 83 25
 >358 to ≤424 82 25
 >424 to ≤557 82 25
 >557 to ≤930 82 25
NOTE. N = 393. Donors who successfully donated (n = 392) and those with graft resected but not transplanted (n = 1).
a
Left lobe weight was obtained from preoperative imaging (69%) or 0.4 × donor standard liver volume (30%) and was missing in 1%.
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Table 4
Initial and Subsequent Hospitalizations of Donors
N Range Mean (SD) or percent
Initial donor hospitalization length of stay (day) 391 2–28 7.0 (2.7)
 ≥2 to <6 98 25
 ≥6 to <7 90 23
 ≥7 to <8 91 23
 ≥8 to ≤28 112 28
No. of rehospitalizations
 0 342 87
 1 37 9
 2 8 2
 3–5 6 2
NOTE. N = 393. Donors who successfully donated (n = 392) and those with graft resected but not transplanted (n = 1).
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Table 6
Factors Associated With Any Complications or Biliary Complications After Donation
Logistic regression model results Odds ratio 95% Confidence interval P value
Any complicationsa
 Units of transfused blood
  None 1.0 — —
  ≤1 2.7 1.6–4.5 <.001
  >1 4.5 2.2–9.4 <.001
Biliary complicationsa
 Alkaline phosphatase (IU/L) ≥86 vs <86 2.99 1.48–6.03 .002
 Units of transfused blood
  None 1.00 — —
  ≤1 3.96 1.86–8.43 <.001
  >1 3.32 1.19–9.29 .022
a
Variables tested and not significant included the following: donor age, sex, ethnicity, race, BMI, relationship to recipient, bilirubin, year of
evaluation, LDLT experience, site, remnant liver volume, number of bile ducts from right lobe, hypotension during surgery, and length of
intraoperative procedure.
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Table 7
Predicted Probabilities of Complications After Donation, by Predictive Factors
Predicted probabilities
Units of red blood cells
None ≤1 >1
Overall complications 0.29 0.52 0.65
Biliary complications
 Low alkaline phosphatase (<86 IU/L) 0.04 0.14 0.12
 High alkaline phosphatase (≥86 IU/L) 0.11 0.33 0.29
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